|
The Role of Oraverse (Phentolamine Mesylate) in Dental Practice
|
Presenter: Dr. Sean Boynes
|
Release Date: 11/10/15
|
|
Credits: 1 CEU, Free Self-Study
|
Expiration Date: 11/10/27
|
|
AGD Subject Code: 340
|
Reviewed: 2024
|
|
Dental patients appreciate options for reducing or eliminating the effects of local anesthetics. Previous reports signify that patients find oral numbness annoying, uncomfortable, and an alteration to quality of life. Agents for anesthetic reversal such as OraVerse can be a useful agent to improve the patient experience and overall appointment satisfaction. This CE webinar will explore OraVerse as an agent in dentistry.
During this CE webinar, the student will:
• Discuss the pharmacology of phentolamine mesylate.
• Develop an understanding of risks and benefits with OraVerse use.
• Discuss clinical use and administration of OraVerse.
( disclaimer
, AGD PACE Statement
)
|
 |
View Class
|
|
Click the arrow to view the training material.
 Desktop and Mobile Compatible
|
Take CE Exam |
|
To earn CE credit you must pass the CE exam.
|
Class Notes |
|
You must be logged in to take notes for this class.
|
